Skip to main content

Table 2 Percentage of SSIs for the different patient categories

From: A retrospective analysis of the risk factors for surgical site infections and long-term follow-up after transpalpebral enucleation in horses

 

no SSI

SSI

Total

ORa

95% confidence intervala

Siga

Lower

Upper

Indication

 Group 1: clean eye

55 (94.8%)

3 (5.2%)

58 (54.2%)

1

  

0.6b

 Group 2: non-clean eye

28 (90.3%)

3 (9.7%)

31 (29%)

2

0.4

10.4

0.4

 Group 3: tumour

16 (88.9%)

2 (11.1%)

18 (16.8%)

2.3

0.4

14.9

0.4

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    

Implant use

 No implant

55 (94.8%)

3 (5.2%)

58 (54.2%)

1

   

 Implant

44 (89.8%)

5 (10.2%)

49 (45.8%)

2.1

0.5

9.2

0.3

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    

Position of the horse

 Recumbent

90 (93.8%)

6 (6.3%)

96 (89.7%)

1

   

 Standing

9 (81.8%)

2 (18.2%)

11 (10.3%)

3.3

0.6

19

0.2

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    

Antibiotic treatment

 Short term

92 (93.9%)

6 (6.1%)

98 (91.6%)

1

   

 Long term

7 (77.8%)

2 (22.2%)

9 (8.4%)

4.4

0.7

25.9

0.1

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    

Surgery time

  < mean surgery time

55 (91.7%)

5 (8.3%)

60 (56.1%)

1.3

0.3

5.9

0.7

  > mean surgery time

44 (93.6%)

3 (6.4%)

47 (43.9%)

1

   

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    

Conjunctival sac

 Not opened

80 (93%)

6 (7%)

86 (80.4%)

1

   

 Opened

19 (90.5%)

2 (9.5%)

21 (19.6%)

1.4

0.3

7.5

0.7

 Total

99 (92.5%)

8 (7.5%)

107 (100%)

    
  1. aValues are from the univariable logistic regression model
  2. bOverall significance for indication